Efficacy and safety of fixed-combination bimatoprost/timolol ophthalmic solution

Affiliations

¹ Department of Surgery, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.
² Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.

Comment

Suk Bae Moon et al. Patient Prefer Adherence. 2017.

. 2017 Jun 26:11:1069-1070.

doi: 10.2147/PPA.S141868. eCollection 2017.

¹ Department of Surgery, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.
² Department of Ophthalmology, Kangwon National University Hospital, Kangwon National University Graduate School of Medicine, Chuncheon, Korea.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this communication.

Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China.
Sun X, Lin M, Duan X, Zhang C, Ming J. Sun X, et al. Patient Prefer Adherence. 2017 Apr 28;11:845-852. doi: 10.2147/PPA.S131853. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28496310 Free PMC article.

1. Sun X, Lin M, Duan X, Zhang C, Ming J. Patient satisfaction with fixed-combination bimatoprost/timolol ophthalmic solution: a survey study in patients with glaucoma in China. Patient Prefer Adherence. 2017;11:845–852. - PMC - PubMed
1. Cho HK, Kee C. Population-based glaucoma prevalence studies in Asians. Surv Ophthalmol. 2014;59(4):434–447. - PubMed
1. Han SB, Hyon JY, Wee WR, Lee JH, Lee YJ, Yun PY. Reduced corneal sensitivity in patients with primary Sjogren’s syndrome. Acta Ophthalmol. 2010;88(7):e277–e278. - PubMed
1. Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153(1):1–9. e2. - PubMed